Clal Insurance’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.7M Sell
3,173,014
-300,000
-9% -$4.52M 0.26% 67
2025
Q4
$62.6M Sell
3,473,014
-440,000
-11% -$7.9M 0.4% 52
2025
Q3
$72.5M Hold
3,913,014
0.55% 45
2025
Q2
$62.6M Buy
3,913,014
+570,000
+17% +$10.2M 0.62% 44
2025
Q1
$65M Sell
3,343,014
-153,095
-4% -$3.22M 0.67% 38
2024
Q4
$77M Sell
3,496,109
-469,838
-12% -$9.04M 0.69% 33
2024
Q3
$66.8M Sell
3,965,947
-3,688,828
-48% -$54.7M 0.59% 42
2024
Q2
$91.5M Buy
7,654,775
+1,582,663
+26% +$17.7M 0.96% 29
2024
Q1
$63M Sell
6,072,112
-1,014,046
-14% -$10.3M 0.71% 38
2023
Q4
$56.4M Buy
7,086,158
+514,858
+8% +$4M 0.74% 35
2023
Q3
$45.3M Buy
+6,571,300
New +$49.3M 0.63% 39

Other funds holding CLBT